Your session is about to expire
← Back to Search
Opioid-Free Anesthesia for Tonsillectomy
Study Summary
This trial will compare two types of anesthesia for tonsillectomy surgery, one with opioids and one without, to see if the opioid-free option is just as good.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have used opioid pain medication in the last 30 days.You have a high risk of bleeding after surgery due to a bleeding disorder or poor blood clotting.You have asthma and have had bad reactions to aspirin or NSAIDs in the past.You have had a bad reaction to NSAIDs before.You have been diagnosed with trisomy 21.You have a chronic illness like sickle cell disease that may require treatment with opioids.Boys and girls between 2 and 18 years oldYou have a history of using drugs, long-lasting pain, or a bleeding disorder.You have a history of liver or kidney problems, low platelet count, or low red blood cell count.You have serious health problems or allergies to certain medications, especially related to heart conditions or bleeding risks.You are following a ketogenic diet.You have an American Society of Anesthesiologists (ASA) physical status score of 3 or lower.
- Group 1: Opioid-Free Group (OFG)
- Group 2: Traditional Care Group (TCG)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment open to minors for this medical experiment?
"This particular medical research is open to minors between 2 and 18 years of age. There are 159 trials specifically for people in this demographic, while 633 studies concentrate on individuals over 65."
Are there other examinations that have been conducted concerning Ketorolac?
"Currently, there are 220 ongoing studies on ketorolac and 49 of them have entered Phase 3. With 425 recruiting sites across the United States, many of which in Boston Massachusetts, this medication is being heavily researched."
To what degree is Ketorolac a secure medication for individuals?
"The safety of Ketorolac has been clinically validated, thus it earned a score of 3."
How many participants is the maximum capacity for this clinical experiment?
"Affirmative, clinicaltrials.gov reveals that the trial is actively seeking participants. Initially posted on July 22nd 2020 and modified as recently as August 29th 2022, this medical research requires 550 individuals to be enrolled from two separate facilities."
Is eligibility for this trial open at the present time?
"Correct. Data held on clinicaltrials.gov suggests that recruitment for this trial, which was originally published on July 22nd 2020, is currently ongoing. Approximately 550 people need to be recruited from 2 distinct medical facilities."
For what medical conditions is Ketorolac commonly prescribed?
"Ketorolac is generally prescribed to reduce the effects of general anesthesia. In addition, it's also utilized in cases such as miosis disorder and intraocular lens replacement."
Could I fulfill the criteria for this experimental research?
"This medical research is seeking 550 pediatric patients between the ages of two and eighteen suffering from tonsillitis. To be eligible, participants must meet these conditions: Male or female with a maximum American Society of Anesthesiologists (ASA) physical classification score 3; post-menarche girls must present a negative pregnancy test result; undergo scheduled tonsillectomy/tonsillectomy in combination with adenoidectomy and/or ear tube placement at the Children's Hospital of Philadelphia (CHOP)'s main or ambulatory surgical centers."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger